Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Income from Continuing Operations (2022 - 2025)

Cannabis Bioscience International Holdings' Income from Continuing Operations history spans 3 years, with the latest figure at 113737.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 60.58% year-over-year to 113737.0; the TTM value through Nov 2025 reached 456484.0, up 14.4%, while the annual FY2025 figure was 421365.0, 34.2% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 113737.0 at Cannabis Bioscience International Holdings, down from 92152.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 70827.0 in Q4 2024 and bottomed at 284868.0 in Q1 2023.
  • The 3-year median for Income from Continuing Operations is 124682.0 (2023), against an average of 154743.67.
  • The largest annual shift saw Income from Continuing Operations surged 54.75% in 2024 before it crashed 60.58% in 2025.
  • A 3-year view of Income from Continuing Operations shows it stood at 124428.0 in 2023, then soared by 43.08% to 70827.0 in 2024, then plummeted by 60.58% to 113737.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Income from Continuing Operations are 113737.0 (Q4 2025), 92152.0 (Q3 2025), and 101387.0 (Q2 2025).